Novel indirect additive manufacturing for processing biomaterials

Abstract

The aim of this work was to identify methods for the production of patient-specific biomedical devices via indirect additive manufacturing (AM) methods. Additive manufacturing has been shown to provide a good solution for the manufacture of patient specific implants, but in a limited range of materials, and at a relatively high cost. This research project considered what are known as “indirect” AM approaches, which typically consider AM in combination with one or more subsequent processes in order to produce a part, with a maxillofacial plate and mandible resection used as a demonstrator application. Three different approaches were considered: (i) using AM to produce moulds for powder pressing of bioceramic green parts for subsequent sintering; (ii) using AM to produce moulds for biopolymer sintering; and (iii) 3D printing of bioceramic powders into green parts for subsequent sintering. Apatite wollastonite glass ceramic (AW) and poly-Lactide-co-glycolide (PLGA) were selected as the bioceramic and biopolymer materials to process. These were characterised before and after processing in order to ensure that the processing route did not affect the material properties. Geometric dimensions, the morphological structure and mechanical properties were studied to establish the accuracy, shrinkage and strength of the fabricated biomaterial implants. The use of AM processes to produce moulds for PLGA sintering, and the 3D printing of bioceramic powders formed the best overall results in terms of the definition and properties of the manufactured parts. Parts produced were accurate to within 5% of the as designed dimensions for both the PLGA sintering and the bioceramic powders 3D printing. The indirect AM methods are considered to be promising processing routes for medical devices.